Clinical characteristics of primary lung cancer patients in a tertiary hospital

Tuberculosis and Respiratory Diseases

Volumn 60, Issue 3, 2006, Pages 321-329

  Ryu, Jeong Seon ^a,b   Lee, Hun Jae ^a   Leem, Jong Han ^a   Kim, Lucia ^a   Lee, Kyung Hee ^a   Cho, Jae Hwa ^a   Yoon, Young Han ^a   Kwak, Seung Min ^a   Lee, Hong Lyeol ^a   Kim, Kwang Ho ^a   Loh, John Kyu ^a   Jung, Soo Kyung ^a  

^a Inha University School of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

Author keywords

Clinical characteristics; Lung cancer; Smoking; Symptom

Indexed keywords

AGE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CANCER PATIENT; CANCER STAGING; CARDIOVASCULAR DISEASE; CELL TYPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCORTICOGRAPHY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; KOREA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG FIBROSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATION; QUESTIONNAIRE; SMOKING; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE;

EID: 33745478866     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2006.60.3.321     Document Type: Article

References (32)

1. Jee SH, Kim IS, Suh I, Shin D, Appel LJ. Projected mortality from lung cancer in South Korea, 1980-2004. Int J Epidemiol 1998;27:365-9.
2. Lam WK. Lung cancer in Asian women-the environment and genes. Respirology 2005;10:408-17.
3. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
4. Oh JK. Clinical aspects of lung cancer. Tuberc Respir Dis 1973;20:24-30.
5. Jung ET. Clinical survey of lung cancer in Korea. Tuberc Respir Dis 2000;49:137-48.
6. Kim HJ, Jeong MP, Heo DS, Bang YJ, Han SK, Shin YS, et al. Lung cancer in Korea (1980-1984). Korean J Med 1994;46:221-8.
7. Lee C, Kang KH, Koh Y, Chang J, Chung HS, Park SK, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22.
8. Kim JS, Park JY, Chae SC, Shin MC, Bae MS, Son JW, et al. Changing trends of clinical aspects in lung cancer from 1988 to 1996-hostipal based study. J Korean Cancer Assoc 1999;31:112-9.
9. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. World Health Organization international histological classification of tumours: histological typing of lung and pleural tumours. 3rd ed. Berlin: Springer; 1999.
10. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
11. International Agency for Research on Cancer. Avail from: http://www.iarc.fr/
12. Moon JD. Manual of problem-solving approach to occupational diseases the Korean National Institute of Occupational Safety and Health. 2003. p. 333-45.
13. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1256-76.
14. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
15. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-6.
16. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75(1 Suppl):191-202.
17. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-46.
18. Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998;21:105-13.
19. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
20. Harris JM, Cullinan P, McDonald JC. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer? J Epidemiol Community Health 1998;52:602-3.
21. Park J, Kim DS, Shim TS, Lim CM, Koh Y, Lee SD, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-9.
22. Hara H, Soejima R, Matsushima T. A study of the coexistence of pulmonary tuberculosis and bronchogenic carcinoma: results of a questionnaire in Chugoku and Shikoku areas. Kekkaku 1990;65:711-7.
23. Aoki Y, Kuroki S, Hiura K, Katoh O, Yamada H. A clinical study of pulmonary tuberculosis in lung cancer patient. Kekkaku 1991;66:727-32.
24. Choi YC, Yoo DH, Lee J, Choi J, Lew WJ, Park SS, et al. Clinical study of lung cancer associated with pulmonary tuberculosis. Tuberc Respir Dis 1989;36:238-45.
25. Rhu NS, Kim SJ, Kim SW, Kim JH, Cho DI, Kim JW, et al. Clinical study of lung cancer associated with pulmonary tuberculosis. Tuberc Respir Dis 1986;33:3542.
26. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312.
27. Kreuzer M, Kreienbrock L, Gerken M, Heinrich J, Bruske-Hohlfeld I, Muller KM, et al. Risk factors for lung cancer in young adults. Am J Epidemiol 1998;147:1028-37.
28. Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH. Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 2000;152:497-505.
29. Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991;44:429-37.
30. Ward EM, Schulte PA, Bayard S, Blair A, Brandt-Rauf P, Butler MA, et al. Priorities for development of research methods in occupational cancer. Environ Health Perspect 2003;111:1-12.
31. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22:462-9.